286 related articles for article (PubMed ID: 31712206)
1.
Fleischmann WA; Greenwood-Quaintance KE; Patel R
Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31712206
[TBL] [Abstract][Full Text] [Related]
2.
Castanheira M; Davis AP; Mendes RE; Serio AW; Krause KM; Flamm RK
Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29866862
[TBL] [Abstract][Full Text] [Related]
3. Comparison of in vitro activities of plazomicin and other aminoglycosides against clinical isolates of Klebsiella pneumoniae and Escherichia coli.
İnce G; Mirza HC; Üsküdar Güçlü A; Gümüş H; Erol Ç; Başustaoğlu A
J Antimicrob Chemother; 2021 Nov; 76(12):3192-3196. PubMed ID: 34499728
[TBL] [Abstract][Full Text] [Related]
4. Carbapenem-resistant Klebsiella pneumoniae strains exhibit diversity in aminoglycoside-modifying enzymes, which exert differing effects on plazomicin and other agents.
Almaghrabi R; Clancy CJ; Doi Y; Hao B; Chen L; Shields RK; Press EG; Iovine NM; Townsend BM; Wagener MM; Kreiswirth B; Nguyen MH
Antimicrob Agents Chemother; 2014 Aug; 58(8):4443-51. PubMed ID: 24867988
[TBL] [Abstract][Full Text] [Related]
5. Nationwide epidemiology of carbapenem resistant Klebsiella pneumoniae isolates from Greek hospitals, with regards to plazomicin and aminoglycoside resistance.
Galani I; Nafplioti K; Adamou P; Karaiskos I; Giamarellou H; Souli M;
BMC Infect Dis; 2019 Feb; 19(1):167. PubMed ID: 30770727
[TBL] [Abstract][Full Text] [Related]
6. Association between the Presence of Aminoglycoside-Modifying Enzymes and In Vitro Activity of Gentamicin, Tobramycin, Amikacin, and Plazomicin against Klebsiella pneumoniae Carbapenemase- and Extended-Spectrum-β-Lactamase-Producing Enterobacter Species.
Haidar G; Alkroud A; Cheng S; Churilla TM; Churilla BM; Shields RK; Doi Y; Clancy CJ; Nguyen MH
Antimicrob Agents Chemother; 2016 Sep; 60(9):5208-14. PubMed ID: 27297487
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial activity of plazomicin against Enterobacteriaceae-producing carbapenemases from 50 Brazilian medical centers.
Martins AF; Bail L; Ito CAS; da Silva Nogueira K; Dalmolin TV; Martins AS; Rocha JLL; Serio AW; Tuon FF
Diagn Microbiol Infect Dis; 2018 Mar; 90(3):228-232. PubMed ID: 29223516
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of plazomicin compared to other clinically relevant aminoglycosides in carbapenem-resistant Enterobacteriaceae.
Clark JA; Kulengowski B; Burgess DS
Diagn Microbiol Infect Dis; 2020 Oct; 98(2):115117. PubMed ID: 32755805
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the next-generation aminoglycoside plazomicin to gentamicin, tobramycin and amikacin.
Zhanel GG; Lawson CD; Zelenitsky S; Findlay B; Schweizer F; Adam H; Walkty A; Rubinstein E; Gin AS; Hoban DJ; Lynch JP; Karlowsky JA
Expert Rev Anti Infect Ther; 2012 Apr; 10(4):459-73. PubMed ID: 22512755
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of plazomicin against β-lactamase-producing carbapenem-resistant Enterobacteriaceae (CRE).
Zhang Y; Kashikar A; Bush K
J Antimicrob Chemother; 2017 Oct; 72(10):2792-2795. PubMed ID: 29091224
[TBL] [Abstract][Full Text] [Related]
11. Plazomicin activity against polymyxin-resistant Enterobacteriaceae, including MCR-1-producing isolates.
Denervaud-Tendon V; Poirel L; Connolly LE; Krause KM; Nordmann P
J Antimicrob Chemother; 2017 Oct; 72(10):2787-2791. PubMed ID: 29091226
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity of plazomicin against 5,015 gram-negative and gram-positive clinical isolates obtained from patients in canadian hospitals as part of the CANWARD study, 2011-2012.
Walkty A; Adam H; Baxter M; Denisuik A; Lagacé-Wiens P; Karlowsky JA; Hoban DJ; Zhanel GG
Antimicrob Agents Chemother; 2014 May; 58(5):2554-63. PubMed ID: 24550325
[TBL] [Abstract][Full Text] [Related]
13. In Vitro Activity of Plazomicin Against Carbapenem Resistant Klebsiella pneumoniae Strains.
Demirbas Z; Ozger HS; Suzuk-Yildiz S; Bakkaloglu Z; Dizbay M
Clin Lab; 2022 Jun; 68(6):. PubMed ID: 35704736
[TBL] [Abstract][Full Text] [Related]
14. Impact of the Recent Clinical and Laboratory Standards Institute Breakpoint Changes on the Antimicrobial Spectrum of Aminoglycosides and the Activity of Plazomicin Against Multidrug-Resistant and Carbapenem-Resistant Enterobacterales From United States Medical Centers.
Sader HS; Mendes RE; Kimbrough JH; Kantro V; Castanheira M
Open Forum Infect Dis; 2023 Feb; 10(2):ofad058. PubMed ID: 36861086
[TBL] [Abstract][Full Text] [Related]
15. Frequency of resistance to kanamycin, tobramycin, netilmicin, and amikacin in gentamicin-resistant gram-negative bacteria.
Seligman SJ
Antimicrob Agents Chemother; 1978 Jan; 13(1):70-3. PubMed ID: 626492
[TBL] [Abstract][Full Text] [Related]
16. Activity of Plazomicin Tested against
Castanheira M; Sader HS; Mendes RE; Jones RN
Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32094137
[TBL] [Abstract][Full Text] [Related]
17. Activity of plazomicin (ACHN-490) against MDR clinical isolates of Klebsiella pneumoniae, Escherichia coli, and Enterobacter spp. from Athens, Greece.
Galani I; Souli M; Daikos GL; Chrysouli Z; Poulakou G; Psichogiou M; Panagea T; Argyropoulou A; Stefanou I; Plakias G; Giamarellou H; Petrikkos G
J Chemother; 2012 Aug; 24(4):191-4. PubMed ID: 23040681
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of the next-generation aminoglycoside plazomicin alone and in combination with colistin, meropenem, fosfomycin or tigecycline against carbapenemase-producing Enterobacteriaceae strains.
Rodríguez-Avial I; Pena I; Picazo JJ; Rodríguez-Avial C; Culebras E
Int J Antimicrob Agents; 2015 Dec; 46(6):616-21. PubMed ID: 26391381
[TBL] [Abstract][Full Text] [Related]
19. Activity of newer aminoglycosides and carbenicillin, alone and in combination, against gentamicin-resistant Pseudomonas aeruginosa.
Marks MI; Hammerberg S; Greenstone G; Silver B
Antimicrob Agents Chemother; 1976 Sep; 10(3):399-401. PubMed ID: 825026
[TBL] [Abstract][Full Text] [Related]
20. Comparative activity of plazomicin against extended-spectrum cephalosporin-resistant Escherichia coli clinical isolates (2012-2017) in relation to phylogenetic background, sequence type 131 subclones, bla
Johnston BD; Thuras P; Porter SB; Clabots C; Johnson JR
Eur J Clin Microbiol Infect Dis; 2021 Oct; 40(10):2069-2075. PubMed ID: 33893571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]